INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2022 • Bombax Healthcare Acquisition Corp • Blank checks • New York
This Agreement, made and entered into effective as of [●], 2021 (“Agreement”), by and between Bombax Healthcare Acquisition Corporation, a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • March 8th, 2022 • Bombax Healthcare Acquisition Corp • Blank checks • New York
Pursuant to paragraphs 1(m) and 3(g) of the Investment Management Trust Agreement between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company (“Trustee”), dated as of [ ], 2021 (“Trust Agreement”), this constitutes our irrevocable instruction to you to (i) in conjunction with the Business Combination (as defined in the Trust Agreement), disburse a per share amount of $______, for a total disbursement of $__________________which is not less than $10.00 to ________________ (the “Shareholder”) for the _____________________ ordinary shares of the Company delivered to you prior to or concurrently herewith for redemption in connection with the Business Combination, and (ii) deliver to the Shareholder the amounts specified in clause (i) prior to delivering and amounts to the Depository Trust Company, the Company, or any person from whom you have not received an irrevocable instruction substantially similar to this one. The Shareholder wire inst
WARRANT AGREEMENTWarrant Agreement • March 8th, 2022 • Bombax Healthcare Acquisition Corp • Blank checks • New York
This Warrant Agreement (“Warrant Agreement”) is made as of [*], 2022, by Bombax Healthcare Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company (the “Warrant Agent”).
Bombax Healthcare Acquisition Corporation 21/F, 88 Gloucester Road, Wan Chai, Hong Kong JonesTrading Institutional Services LLC 757 3rd Avenue, 23rd floor New York, NY 10017 Re: Initial Public Offering Ladies and Gentlemen:Underwriting Agreement • March 8th, 2022 • Bombax Healthcare Acquisition Corp • Blank checks
This letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Bombax Healthcare Acquisition Corporation, a Cayman Islands company (the “Company”), and JonesTrading Institutional Services LLC, as Representative (the “Representative”) of the several underwriters named on Schedule A thereto (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one Class A ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one-half (1/2) of one redeemable warrant, each whole warrant entitling its holder to purchase one Class A Ordinary Share at an exercise price of $11.50 per full share (the “Warrants”). Certain capitalized terms used herein are defined in paragraph 14 hereof.
BOMBAX HEALTHCARE ACQUISITION CORPORATION 5,000,000 Units Underwriting AgreementBombax Healthcare Acquisition Corp • March 8th, 2022 • Blank checks • New York
JonesTrading Institutional Services LLC As Representative of the several Underwriters listed in Schedule 1 hereto c/o JonesTrading Institutional Services LLC 757 Third Avenue, 23rd Floor New York, NY 10017
BOMBAX HEALTHCARE ACQUISITION CORPORATION 21/F, 88 Gloucester Road, Wan Chai, Hong KongBombax Healthcare Acquisition Corp • March 8th, 2022 • Blank checks • New York
This letter agreement by and between Bombax Healthcare Acquisition Corporation (the “Company”) and Bombax Capital Partners Limited (“Bombax Capital”) will confirm our agreement that, commencing on the date the securities of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 (Registration No. 333-[ ]) and related prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination (as defined in the Registration Statement) or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):
